Jim Cramer made some predictions about the stock market in 2016 while answering viewers’ social media questions on the floor of the New York Stock Exchange Tuesday. Cramer said he wouldn’t be surprised to see Exxon Mobil (XOM) and Chevron (CVX) make some acquisitions. He also expects Eli Lilly (LLY) will go to $100 a share as investors start seeing some results from its Alzheimer’s drug. Cramer was asked about technology companies IBM (IBM) and Hewlett Packard (HPQ). Cramer said only about 28 percent of IBM’s business is fast growing, and that the company needs to make an acquisition to spur growth. Cramer said he’s not interested in either Hewlett Packard or its spin-off, Hewlett Packard Enterprise (HP), until he sees a couple of quarters of earnings. He does thinks the printer and PC business should buy Lexmark (LXK). A viewer asked whether to hold Rite Aid (RAD), and Cramer said he’s not sure if its deal with Walgreens (WAG) will win approval, but if you want to be an arbitrageur you hold onto it. Cramer was asked, if you could start a new position in either Disney (DIS) or Apple (AAPL) which would you choose? Cramer responded that he likes Disney because it has some catalysts ahead of it, while Apple does not. Cramer was asked about Bank of America (BAC), which he thinks could go to $20, depending on the course of future interest rate increases by the Federal Reserve. More aggressive rate increases would benefit the bank. ’ You can send your questions to Cramer on his Facebook(FB) page, or on Twitter(TWTR), where he’s @jimcramer. Use hashtag CramerQ.
More from Video
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.